TABLE 3.
Outcomes | Prospective cohort |
---|---|
Pregnancy outcomes, n (%) | N = 55 pregnancies |
Live birth | 53 (96) |
Miscarriage | 2 (4) |
Molar pregnancy | 0 |
Ectopic pregnancy | 0 |
Elective termination | 0 |
Stillbirth | 0 |
Infant outcomes | |
At birth, n (%) | N = 56 infants |
Pre‐term birth a | 16 (29) |
Neonatal death | 0 |
SGA b | 4 (7) |
SGA c | 11 (20) |
At 4 months, n (%) | N = 46 infants |
Infants with at least one infection or fever d | 6 (13) |
Developmental milestone delayed by type e | |
Gross motor | 1 (2) |
Fine motor | 0 |
Cognitive | 0 |
Socio‐emotional | 0 |
Language | 0 |
At 12 months, n (%) | N = 43 infants |
Infants with at least one infection or fever d | 14 (33) |
Developmental milestone delayed by type e | |
Gross motor | 2 (5) |
Fine motor | 1 (2) |
Cognitive | 0 |
Socio‐emotional | 1 (2) |
Language | 2 (5) |
Abbreviations: ACOG, American College of Obstetricians and Gynecologists; BPR, Belimumab Pregnancy Registry; INTERGROWTH‐21st, International Fetal and Newborn Growth Consortium for the 21st Century; SGA, small for gestational age.
Includes infants from two sets of twins;
INTERGROWTH‐21st criteria;
ACOG criteria;
Any infection or fever of “unknown origin” or “of known infectious etiology that occurs through three months of age for an infant”;
Provided by the pediatrician and combined across gross motor, fine motor, cognitive, socio‐emotional, and language milestones for cases where this information was available.